Published in Am J Pathol on December 01, 1996
Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent. Int J Exp Pathol (1999) 0.77
Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem (1985) 6.28
IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol (1989) 3.15
Defective inflammatory response in interleukin 6-deficient mice. J Exp Med (1994) 2.92
Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A (1995) 2.11
Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem (1995) 1.83
Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development (1996) 1.26
Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor. J Exp Med (1992) 1.12
Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc Natl Acad Sci U S A (1995) 1.04
Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. Am J Physiol (1994) 1.00
Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol (1994) 0.97
A new hepatocyte stimulating factor: cardiotrophin-1 (CT-1). FEBS Lett (1995) 0.86
Murine cardiotrophin-1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. J Interferon Cytokine Res (1996) 0.86
Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med (1992) 0.85
cDNA cloning of rat cardiotrophin-1 (CT-1): augmented expression of CT-1 gene in ventricle of genetically hypertensive rats. Biochem Biophys Res Commun (1996) 0.81
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature (1985) 13.04
Expression of human immune interferon cDNA in E. coli and monkey cells. Nature (1982) 6.55
The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature (1996) 5.69
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature (1983) 5.27
Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res (1985) 5.22
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A (2000) 5.20
Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci U S A (1985) 4.42
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity (1997) 4.19
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80
Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell (1998) 3.25
Defective inflammatory response in interleukin 6-deficient mice. J Exp Med (1994) 2.92
WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev (2000) 2.67
Detecting chlorophyll, Secchi disk depth and surface temperature in a sub-alpine lake using Landsat imagery. Sci Total Environ (2001) 2.49
Tumor necrosis factors: gene structure and biological activities. Cold Spring Harb Symp Quant Biol (1986) 2.38
Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem (1993) 2.29
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci U S A (1991) 2.24
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation (2000) 2.19
The amino acid sequence of murine p53 determined from a c-DNA clone. Virology (1984) 2.15
Prostacyclin synthesis induced in vascular cells by interleukin-1. Science (1985) 2.13
Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med (1988) 2.10
Identification of a mouse homolog of the human BTEB2 transcription factor as a beta-catenin-independent Wnt-1-responsive gene. Mol Cell Biol (2001) 1.98
Identification of human uromodulin as the Tamm-Horsfall urinary glycoprotein. Science (1987) 1.92
Effect of endotoxin in IL-1 beta-deficient mice. J Immunol (1996) 1.92
Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1 beta. J Immunol (1986) 1.87
Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med (1999) 1.84
Regulation of the macrophage content of neoplasms by chemoattractants. Science (1983) 1.83
Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res (1990) 1.77
Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem (1996) 1.69
Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol (1989) 1.51
Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes Dev (2001) 1.49
Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock (1997) 1.48
Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours. Cytokine (2001) 1.44
Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids. Biochem J (1991) 1.40
Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. Cancer Res (2001) 1.40
Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis (1990) 1.39
Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology (2004) 1.33
WISP-1 binds to decorin and biglycan. J Biol Chem (2001) 1.32
Recombinant tumor necrosis factor/cachectin and interleukin 1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia. J Clin Invest (1987) 1.32
Molecular cloning of a cDNA coding for mouse liver xanthine dehydrogenase. Regulation of its transcript by interferons in vivo. Biochem J (1992) 1.30
Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med (1991) 1.27
Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development (1996) 1.26
Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J Neurosci (2001) 1.24
IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J Immunol (1990) 1.24
Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Science (1993) 1.23
Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor. Mediators Inflamm (1997) 1.21
Interferon-gamma induces receptor dimerization in solution and on cells. J Biol Chem (1993) 1.13
Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema. J Lab Clin Med (1994) 1.12
Cytokine down-regulation in endotoxin tolerance. Eur Cytokine Netw (1993) 1.12
Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci U S A (2001) 1.11
Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron. J Leukoc Biol (1989) 1.10
N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol (1992) 1.10
Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol (2000) 1.10
Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Clin Exp Immunol (1993) 1.09
Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infect Immun (1986) 1.09
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice. J Immunol (1987) 1.08
Separation and purification of the mRNAs for vesicular stomatitis virus NS and M proteins. Virology (1979) 1.07
Induction of indoleamine dioxygenase by interferon in mice: a study with different recombinant interferons and various cytokines. Biochem Biophys Res Commun (1988) 1.07
Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem Biophys Res Commun (1984) 1.05
Redox regulation of chemokine receptor expression. Proc Natl Acad Sci U S A (2000) 1.04
IFN-beta-induced reduction of superoxide anion generation by macrophages. Immunology (1982) 1.04
Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J Exp Med (1990) 1.03
Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice. Cancer Res (1985) 1.02
Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. Clin Exp Allergy (2001) 1.01
Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J Mol Cell Cardiol (2000) 1.01
Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues. Int J Cancer (1985) 1.01
Regulation of inhibitory pathways of the interleukin-1 system. Ann N Y Acad Sci (1998) 1.01
Enhancement of in vivo immune response by tumor necrosis factor. J Immunol (1987) 1.00
Interferons induce xanthine dehydrogenase gene expression in L929 cells. Biochem J (1992) 1.00
Synergistic effects of schwann- and muscle-derived factors on motoneuron survival involve GDNF and cardiotrophin-1 (CT-1). J Neurosci (1998) 1.00
Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. J Mol Cell Cardiol (1998) 1.00
Central nervous system vasculitis. Neurol Sci (2003) 0.99
Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer (1983) 0.99
Report and abstracts on the first international workshop on the CCN family of genes. Mol Pathol (2001) 0.99
Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proc Natl Acad Sci U S A (1995) 0.99
Cytokines promote the survival of mouse cranial sensory neurones at different developmental stages. Eur J Neurosci (1998) 0.98
Interleukin 6 activity in infants and children with bacterial meningitis. The Collaborative Study on Meningitis. Pediatr Infect Dis J (1991) 0.98
The extracellular domain of the human interferon gamma receptor interacts with a species-specific signal transducer. Mol Cell Biol (1991) 0.98
Lps induces IL-6 in the brain and in serum largely through TNF production. Cytokine (2000) 0.98
MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain. Neurosci Lett (1998) 0.97
Purification and characterization of mouse liver xanthine oxidase. Arch Biochem Biophys (1990) 0.97
Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice. Biochem Biophys Res Commun (1986) 0.96
Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells. J Pharmacol Exp Ther (1984) 0.96
Autocrine interleukin-1 beta regulates both proliferation and apoptosis in EL4-6.1 thymoma cells. Blood (1995) 0.95
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol (1994) 0.95
Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component. J Biol Chem (1997) 0.95
B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection. Rheumatology (Oxford) (2006) 0.94
Decay of vesicular stomatitis virus mRNAs in vivo. Virology (1979) 0.94
Hyperresponsive febrile reactions to interleukin (IL) 1alpha and IL-1beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1beta-deficient mice. Proc Natl Acad Sci U S A (1997) 0.94
Reversal of defective IL-6 production in lipopolysaccharide-tolerant mice by phorbol myristate acetate. J Immunol (1991) 0.93
IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice. J Immunol (1997) 0.93
Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin. Am J Physiol (1998) 0.93
Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity. Immunology (1983) 0.93
Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin 1 and tumor necrosis factor: a comparison with lymphotoxin and interferon. Int J Immunopharmacol (1988) 0.93
Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis. J Infect Dis (1998) 0.92